[DNLI] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -154.18%
YoY- 3.82%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 -305,043 1,267 294,123 35,141 10,283 -
PBT -99,026 -101,802 -119,443 -99,353 183,383 -109,781 -98,684 0.23%
Tax 0 2,119 30 2,257 -2,285 -10,047 -6 -
NP -99,026 -101,802 -119,473 -99,353 183,383 -109,781 -98,678 0.23%
Tax Rate - - - - 1.25% - - -
Total Cost 99,026 101,802 -185,570 100,620 110,740 144,922 108,961 -6.18%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 39.17 -7,841.59 62.35 -312.40 -959.62 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.59 -0.68 -0.86 -0.72 1.34 -0.80 -0.74 -14.02%
EPS Diluted -0.59 -0.68 -0.86 -0.72 1.30 -0.80 -0.74 -14.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.